Cardio polypill: Prevention on the cheap?

An experimental pill combining aspirin, cholesterol medicine and blood pressure meds--everything people need to prevent heart attacks and strokes--was as effective as nearly all of its components taken alone, with no greater side effects, a major study found. Taking the generic "polypill" could cut a person's risk of heart disease and stroke roughly in half, at a much lower cost, researchers said. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

A phase 1 study of the Inlyta-Keytruda regimen, which bears a first-line nod for kidney cancer, got the ax along with several Bavencio tests.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.